We are live on ! Find out more

3,435 hedge funds and large institutions have $216B invested in Merck in 2023 Q4 according to their latest regulatory filings, with 378 funds opening new positions, 1,245 increasing their positions, 1,486 reducing their positions, and 107 closing their positions.

New
Increased
Maintained
Reduced
Closed

253% more first-time investments, than exits

New positions opened: 378 | Existing positions closed: 107

10% more call options, than puts

Call options by funds: $1.92B | Put options by funds: $1.75B

9% more capital invested

Capital invested by funds: $199B → $216B (+$17.4B)

7% more funds holding

Funds holding: 3,2143,435 (+221)

2.47% more ownership

Funds ownership: 75.65%78.12% (+2.5%)

5% less funds holding in top 10

Funds holding in top 10: 186177 (-9)

16% less repeat investments, than reductions

Existing positions increased: 1,245 | Existing positions reduced: 1,486

Holders
3,435
Holders Change
+221
Holders Change %
+6.88%
% of All Funds
50.07%
Holding in Top 10
177
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-4.84%
% of All Funds
2.58%
New
378
Increased
1,245
Reduced
1,486
Closed
107
Calls
$1.92B
Puts
$1.75B
Net Calls
+$175M
Net Calls Change
-$230M
Name Holding Trade Value Shares
Change
Change in
Stake
BP
876
Ballentine Partners
Massachusetts
$6.92M +$1.01M +9,690 +18%
CAL
877
Capital Analysts LLC
Pennsylvania
$6.91M -$92.4K -890 -1%
AAIM
878
Asset Advisors Investment Management
Georgia
$6.9M -$449K -4,324 -6%
GCM
879
Garland Capital Management
Washington
$6.86M -$253K -2,435 -4%
SWM
880
SeaCrest Wealth Management
New York
$6.85M -$527K -5,081 -8%
VPI
881
Value Partners Investments
Manitoba, Canada
$6.83M +$1.2M +11,586 +23%
RDWM
882
Red Door Wealth Management
Tennessee
$6.83M +$253K +2,441 +4%
EH
883
Equitable Holdings
New York
$6.82M +$662K +6,373 +11%
OLA
884
Oliver Luxxe Assets
New Jersey
$6.81M +$39.1K +377 +0.6%
ACM
885
Argyle Capital Management
Pennsylvania
$6.81M -$958K -9,225 -13%
FM
886
Freemont Management
Switzerland
$6.8M
PCA
887
Pallas Capital Advisors
Massachusetts
$6.8M +$236K +2,270 +4%
BOC
888
Barbara Oil Co
Illinois
$6.79M
CC
889
Capital Counsel
New York
$6.78M
USCWA
890
U.S. Capital Wealth Advisors
Texas
$6.77M +$87.3K +841 +1%
MPI
891
Mairs & Power Inc
Minnesota
$6.76M +$274K +2,639 +4%
JCM
892
Jacobi Capital Management
Pennsylvania
$6.74M +$191K +1,844 +3%
WI
893
Wafra Inc
New York
$6.74M -$1.41M -13,599 -18%
SWA
894
Stratos Wealth Advisors
Ohio
$6.73M +$230K +2,216 +4%
ECM
895
Exchange Capital Management
Michigan
$6.72M -$15.7K -151 -0.2%
BRM
896
Boston Research & Management
Massachusetts
$6.71M +$147K +1,415 +2%
RCP
897
Rothschild Capital Partners
New York
$6.7M -$5.5K -53 -0.1%
PHS
898
Pekin Hardy Strauss
Illinois
$6.68M -$12.7K -122 -0.2%
MIA
899
MainStreet Investment Advisors
Illinois
$6.66M -$160K -1,538 -2%
CAM
900
Covenant Asset Management
New Jersey
$6.64M -$262K -2,522 -4%

MRK Hedge Fund Activity: Q4 2023 in Review

3,435 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2023, worth a combined $216B — up 8.8% from $199B a quarter earlier.

Buyers outnumbered sellers: 378 funds opened new MRK positions and 107 closed out — a net gain of 271 holders — while 1,245 added to existing stakes and 1,486 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $4.32B. The largest seller was Bank of New York Mellon, cutting an estimated $432M.

  • 3,435 institutional investors held Merck (MRK) as of Q4 2023, up from 3,214 in Q3 2023.
  • Funds reported $216B of Merck stock for Q4 2023, up 8.8% quarter-over-quarter.
  • 378 funds opened new Merck positions in Q4 2023 and 107 closed out, a net change of +271 holders.
  • The largest Merck buyer in Q4 2023 was Morgan Stanley, an estimated $4.32B added.
  • The largest Merck seller in Q4 2023 was Bank of New York Mellon, an estimated $432M sold.

Based on aggregated 13F filings for Q4 2023.